Clinical Trials: Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma
Sponsor and Collaborators
National Cancer Institute (NCI)
Contact
NCI Referral Office
1-888-NCI-1937
Principal Investigator
None indicated
ClinicalTrials.gov Identifier
NCT00942877
